{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-034212","form_type":"8-K/A","ticker":"FOXO","cik":"0001812360","company_name":"FOXO TECHNOLOGIES INC.","filed_at":"2024-08-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.615311+00:00","generated_at":"2026-05-31T07:14:01.204317+00:00","sec_items":["2.01","9.01"],"event_type":"m_and_a","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"FOXO files financials for Myrtle Recovery acquisition; Myrtle had $1.1M net loss in 2023","bullets":["Acquired 98.4% of Myrtle for $500k consideration: 1,023,629 FOXO shares ($0.23/share) plus $264,565 demand note.","Myrtle's audited FY2023: net loss $1,086,357, revenue $139,550, negative equity $1,118,553.","Myrtle's auditor notes substantial doubt as going concern due to recurring losses and working capital deficit of $1.4M.","Myrtle operates two Tennessee-licensed behavioral health facilities; started accepting patients in Aug 2023.","Pro forma financials filed for FOXO for six months ended June 30, 2024 and year ended Dec 31, 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-034212","json":"https://secwatch.observer/filing/0001493152-24-034212.json","markdown":"https://secwatch.observer/filing/0001493152-24-034212.md","text":"https://secwatch.observer/filing/0001493152-24-034212.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1812360/000149315224034212/0001493152-24-034212-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1812360/000149315224034212/form8-ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T07:14:01.204317+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"675b7cf814fecb893baeaae36ac3389b42e559bd","claim":"FOXO TECHNOLOGIES INC. completed an acquisition involving Rennova Health, Inc. for $500,000 (closed 2024-07-17).","evidence_excerpt":"exchanged with the Company 100 shares of Common Stock of Myrtle (which represents 98.4% of the issued and outstanding shares of Myrtle Common Stock) for total consideration of $500,000 (the “ Myrtle Purchase Price ”), which payment was made by the issuance of a number of shares of Class A Common Stock of the Company determined by dividing $500,000 by the volume","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1812360/000149315224034212/0001493152-24-034212-index.htm","confidence":0.9,"family_label":"M&A Transactions","details":[{"label":"Action","value":"acquisition"},{"label":"Counterparty","value":"Rennova Health, Inc."},{"label":"Consideration","value":"$500,000"},{"label":"Closing","value":"2024-07-17"}],"fact_type":"ma_transaction"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}